INTELLIPHARMACEUTICS INTERNATIONAL INC. Research and Development Expense
INTELLIPHARMACEUTICS INTERNATIONAL INC. reported Research and Development Expense of $1.55 million for the 3-month period ending 2023-08-31, per its 6-K filed 2023-10-16.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2024-02-06
- INTELLIPHARMACEUTICS INTERNATIONAL INC. research and development expense for the quarter ending 2017-05-31 was 2.68M CAD, a 83.56% increase year-over-year.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. research and development expense for the quarter ending 2017-02-28 was 2.03M CAD, a 12.06% increase year-over-year.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. research and development expense for the quarter ending 2016-05-31 was 1.46M CAD.
- INTELLIPHARMACEUTICS INTERNATIONAL INC. research and development expense for the quarter ending 2016-02-29 was 1.81M CAD.
CAD
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 12 month |
|---|---|---|---|
| 2018-11-30 | 10.83M CAD 20-F · filed 2019-03-04 | ||
| 2017-11-30 | 9.27M CAD 20-F · filed 2019-03-04 | ||
| 2017-05-31 | 2.68M CAD 6-K · filed 2017-07-11 | 4.71M CAD 6-K · filed 2017-07-11 | |
| 2017-02-28 | 2.03M CAD 6-K · filed 2017-04-12 | ||
| 2016-11-30 | 8.17M CAD 20-F · filed 2019-03-04 | ||
| 2016-05-31 | 1.46M CAD 6-K · filed 2017-07-11 | 3.27M CAD 6-K · filed 2017-07-11 | |
| 2016-02-29 | 1.81M CAD 6-K · filed 2017-04-12 | ||
| 2015-11-30 | 7.25M CAD 20-F · filed 2018-03-01 | ||
| 2014-11-30 | 8.02M CAD 20-F · filed 2017-02-28 |
USD
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 11 month | Research and Development Expense 12 month |
|---|---|---|---|---|---|---|
| 2023-08-31 | $1.55M 6-K · filed 2023-10-16 | $1.93M derived: sum of 2 quarters · filed 2023-10-16 | $1.57M 6-K · filed 2023-10-16 | $2.87M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2023-05-31 | $377.51K 6-K · filed 2023-09-26 | $825.67K 6-K · filed 2023-09-26 | $1.31M derived: sum of 3 quarters · filed 2024-02-06 | $1.94M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2023-02-28 | $448.17K 6-K · filed 2023-09-26 | $934.65K derived: sum of 2 quarters · filed 2024-02-06 | $1.56M derived: sum of 3 quarters · filed 2024-02-06 | $2.52M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2022-11-30 | $486.48K derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | $1.11M derived: sum of 2 quarters · filed 2024-02-06 | $2.07M derived: sum of 3 quarters · filed 2024-02-06 | $2.15M 20-F/A · filed 2024-02-06 | ||
| 2022-08-31 | $626.07K 6-K · filed 2023-10-16 | $1.58M derived: sum of 2 quarters · filed 2023-10-16 | $1.66M 6-K · filed 2023-10-16 | $2.06M 6-K · filed 2022-10-14 | $3.13M derived: sum of 4 quarters · filed 2024-02-06 | |
| 2022-05-31 | $956.85K 6-K · filed 2023-09-26 | $1.43M 6-K · filed 2023-09-26 | $2.50M derived: sum of 3 quarters · filed 2024-02-06 | $3.23M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2022-02-28 | $543.99K 6-K · filed 2023-09-26 | $1.55M derived: sum of 2 quarters · filed 2024-02-06 | $2.27M derived: sum of 3 quarters · filed 2024-02-06 | $2.75M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2021-11-30 | $1.00M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | $1.73M derived: sum of 2 quarters · filed 2024-02-06 | $2.21M derived: sum of 3 quarters · filed 2024-02-06 | $2.66M 20-F/A · filed 2024-02-06 | ||
| 2021-08-31 | $723.22K 6-K · filed 2022-10-14 | $1.20M derived: sum of 2 quarters · filed 2022-10-14 | $1.66M 6-K · filed 2022-10-14 | $2.84M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2021-05-31 | $481.68K 6-K · filed 2022-07-21 | $1.03M 6-K · filed 2022-07-21 | $2.12M derived: sum of 3 quarters · filed 2024-02-06 | $2.96M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2021-02-28 | $547.49K 6-K · filed 2022-04-14 | $1.64M derived: sum of 2 quarters · filed 2024-02-06 | $2.48M derived: sum of 3 quarters · filed 2024-02-06 | $3.12M derived: sum of 4 quarters · filed 2024-02-06 | ||
| 2020-11-30 | $1.09M derived: 20-F/A 12 month − 6-K 9 month · filed 2024-02-06 | $1.93M derived: sum of 2 quarters · filed 2024-02-06 | $2.57M derived: sum of 3 quarters · filed 2024-02-06 | $3.52M 20-F/A · filed 2024-02-06 | ||
| 2020-08-31 | $842.85K 6-K · filed 2021-10-15 | $1.48M derived: sum of 2 quarters · filed 2021-10-15 | $2.43M 6-K · filed 2021-10-15 | $3.62M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-05-31 | $635.33K 6-K · filed 2021-07-15 | $1.58M 6-K · filed 2021-07-15 | $2.78M derived: sum of 3 quarters · filed 2022-05-09 | $4.40M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2020-02-29 | $947.85K 6-K · filed 2021-04-14 | $2.14M derived: sum of 2 quarters · filed 2022-05-09 | $3.77M derived: sum of 3 quarters · filed 2022-05-09 | $5.42M derived: sum of 4 quarters · filed 2022-05-09 | ||
| 2019-11-30 | $1.20M derived: 20-F/A 12 month − 6-K 9 month · filed 2022-05-09 | $2.82M derived: sum of 2 quarters · filed 2022-05-09 | $4.48M derived: sum of 3 quarters · filed 2022-05-09 | $6.61M 20-F/A · filed 2022-05-09 | ||
| 2019-08-31 | $1.63M 6-K · filed 2020-10-15 | $3.28M derived: sum of 2 quarters · filed 2020-10-15 | $5.41M 6-K · filed 2020-10-15 | $8.46M derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2019-05-31 | $1.66M 6-K · filed 2020-07-15 | $3.79M 6-K · filed 2020-07-15 | $6.83M derived: sum of 3 quarters · filed 2021-03-31 | $10.16M derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2019-02-28 | $2.13M 6-K · filed 2020-05-29 | $5.18M derived: sum of 2 quarters · filed 2021-03-31 | $8.50M derived: sum of 3 quarters · filed 2021-03-31 | $10.70M derived: sum of 4 quarters · filed 2021-03-31 | ||
| 2018-11-30 | $3.04M derived: 20-F 12 month − 6-K 9 month · filed 2021-03-31 | $6.37M derived: sum of 2 quarters · filed 2021-03-31 | $8.56M derived: sum of 3 quarters · filed 2021-03-31 | $10.83M 20-F · filed 2021-03-31 | ||
| 2018-08-31 | $3.32M 6-K · filed 2019-10-11 | $5.52M derived: sum of 2 quarters · filed 2019-10-11 | $7.78M 6-K · filed 2019-10-11 | $10.05M derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2018-05-31 | $2.20M 6-K · filed 2019-07-10 | $4.46M 6-K · filed 2019-07-10 | $6.72M derived: sum of 3 quarters · filed 2020-03-30 | $9.02M derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2018-02-28 | $2.26M 6-K · filed 2019-04-15 | $4.53M derived: sum of 2 quarters · filed 2020-03-30 | $6.83M derived: sum of 3 quarters · filed 2020-03-30 | $9.50M derived: sum of 4 quarters · filed 2020-03-30 | ||
| 2017-11-30 | $2.26M derived: 20-F 12 month − 6-K 9 month · filed 2020-03-30 | $4.56M derived: sum of 2 quarters · filed 2020-03-30 | $7.24M derived: sum of 3 quarters · filed 2020-03-30 | $9.27M 20-F · filed 2020-03-30 | ||
| 2017-08-31 | $2.30M 6-K · filed 2018-10-15 | $4.98M derived: sum of 2 quarters · filed 2018-10-15 | $7.01M 6-K · filed 2018-10-15 | |||
| 2017-05-31 | $2.68M 6-K · filed 2018-07-24 | $4.71M 6-K · filed 2018-07-24 | ||||
| 2015-11-30 | $7.25M 20-F · filed 2016-03-21 | |||||
| 2014-11-30 | $8.02M 20-F · filed 2016-03-21 | |||||
| 2014-02-28 | $1.36M 6-K · filed 2014-04-14 | |||||
| 2013-11-30 | $5.08M 20-F · filed 2016-03-21 | |||||
| 2013-02-28 | $1.34M 6-K · filed 2014-04-14 | |||||
| 2012-11-30 | $5.99M 20-F · filed 2015-02-27 | |||||
| 2011-11-30 | $5.13M 20-F · filed 2014-02-18 | |||||
| 2010-11-30 | $4.53M 20-F/A · filed 2013-02-01 | |||||
| 2009-11-30 | $1.94M 20-F · filed 2012-05-11 |